Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 4, 2009, Pages

  Li, Longhu ^a   Okada, Hideshi ^a   Takemura, Genzou ^a   Kosai, Ken Ichiro ^b   Kanamori, Hiromitsu ^a   Esaki, Masayasu ^a   Takahashi, Tomoyuki ^c   Goto, Kazuko ^a   Tsujimoto, Akiko ^a   Maruyama, Rumi ^a   Kawamura, Itta ^a   Kawaguchi, Tomonori ^a   Takeyama, Toshiaki ^a   Fujiwara, Takako ^d   Fujiwara, Hisayoshi ^a   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Heart failure; Myocardial infarction; Transforming growth factor

Indexed keywords

ADENOVIRUS VECTOR; DECORIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; GENE THERAPY; GRANULATION TISSUE; HEART DISEASE; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEFT CORONARY ARTERY; MORPHOMETRICS; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALVAGE THERAPY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; FIBROSIS; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTEOGLYCANS; SMAD2 PROTEIN; SMAD3 PROTEIN; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 70349616564     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00194.2009     Document Type: Article

References (56)

1. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C, Roberts AB. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1: 260-266, 1999. (Pubitemid 129495775)
2. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001. (Pubitemid 32497029)
3. Bourassa MG, Gurné O, Bangdiwala SI, Ghali JK, Young JB, Rousseau M, Johnstone DE, Yusuf S. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 22, Suppl A: 14A-19A, 1993.
4. Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116: 2127-2138, 2007. (Pubitemid 350060350)
5. Burlew BS, Weber KT. Connective tissue and the heart: functional significance and regulatory mechanisms. Cardiol Clin 18: 435-442, 2000.
6. Chen SH, Chen XH, Wang Y, Kosai K, Finegold MJ, Rich SS, Woo SL. Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 92: 2577-2581, 1995.
7. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, Krajewski S, Reed JC, Olivetti G, Anversa P. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226: 316-327, 1996. (Pubitemid 26260556)
8. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003. (Pubitemid 37280136)
9. Desmoulière A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146: 56-66, 1995.
10. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 33: 1191-1207, 2001. (Pubitemid 32579285)
11. Doran JP, Howie AJ, Townend JN. Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections. J Clin Pathol 49: 34-37, 1996.
12. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503, 2003. (Pubitemid 36818250)
13. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97: 282-289, 1998. (Pubitemid 28067315)
14. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL, Bonow RO. Navigating the crossroads of coronary artery disease and heart failure. Circulation 114: 1202-1213, 2006. (Pubitemid 44386485)
15. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV. Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21: 4765-4777, 2002. (Pubitemid 34879452)
16. Hamner JB, Ellison KJ. Predictors of hospital readmission after discharge in patients with congestive heart failure. Heart Lung 34: 231-239, 2005.
17. Hao J, Ju H, Zhao S, Junaid A, Scammell-La Fleur T, Dixon IM. Elevation of expression of Smad2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31: 667-678, 1999. (Pubitemid 29121651)
18. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997. (Pubitemid 28013118)
19. Huang SS, Huang JS. TGF-beta control of cell proliferation. J Cell Biochem 96: 447-462, 2005.
20. Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 55: 465-475, 1999. (Pubitemid 29082873)
21. Jahanyar J, Joyce DL, Southard RE, Loebe M, Noon GP, Koerner MM, Torre-Amione G, Youker KA. Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. J Heart Lung Transplant 26: 34-40, 2007. (Pubitemid 46096736)
22. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64: 1041-1050, 1989. (Pubitemid 19155774)
23. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 4: 51-58, 2002.
24. Kaiser J. Clinical research. Death prompts a review of gene therapy vector. Science 317: 580, 2007.
25. Krusius T, Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 83: 7683-7687, 1986. (Pubitemid 17183911)
26. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397-1402, 2002. (Pubitemid 35239711)
27. Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, Goto K, Mikami A, Maruyama R, Minatoguchi S, Fujiwara T, Fujiwara H. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res 95: 627-1236, 2004. (Pubitemid 39274378)
28. Li Y, Li J, Zhu J, Sun B, Branca M, Tang Y, Foster W, Xiao X, Huard J. Decorin gene transfer promotes muscle cell differentiation and muscle regeneration. Mol Ther 15: 1616-1622, 2007. (Pubitemid 47289004)
29. Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta 1. Mol Genet Metab 71: 418-435, 2000. (Pubitemid 30749566)
30. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 286: 2244-2245, 1999. (Pubitemid 30016842)
31. Masuda H, Takakura Y, Hashida M. Pharmacokinetics and disposition characteristics of recombinant decorin after intravenous injection into mice. Biochim Biophys Acta 1426: 420-428, 1999.
32. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 74: 693-702, 1986. (Pubitemid 16007186)
33. Mizuguchi H, Kay MA. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Hum Gene Ther 10: 2013-2017, 1999. (Pubitemid 29387915)
34. Nagata S. Apoptosis by death factor. Cell 88: 355-365, 1997.
35. Nakagawa M, Takemura G, Kanamori H, Goto K, Maruyama R, Tsujimoto A, Ohno T, Okada H, Ogino A, Esaki M, Miyata S, Li L, Ushikoshi H, Aoyama T, Kawasaki M, Nagashima K, Fujiwara T, Minatoguchi S, Fujiwara H. Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling. Circ Res 103: 98-106, 2008.
36. Ogino A, Takemura G, Kanamori H, Okada H, Maruyama R, Miyata S, Esaki M, Nakagawa M, Aoyama T, Ushikoshi H, Kawasaki M, Minatoguchi S, Fujiwara T, Fujiwara H. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. Am J Physiol Heart Circ Physiol 293: H2271-H2280, 2007.
37. Okada H, Takemura G, Kosai K, Li Y, Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, Minatoguchi S, Fujiwara T, Fujiwara H. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111: 2430-2437, 2005. (Pubitemid 40696130)
38. Okada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T, Nagano S, Kanamori H, Miyata S, Li Y, Ohno T, Maruyama R, Ogino A, Li L, Nakagawa M, Nagashima K, Fujiwara T, Fujiwara H, Minatoguchi S. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure. Am J Physiol Heart Circ Physiol 296: H616-H626, 2009.
39. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 46: 455-466, 1995.
40. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ, Iozzo RV. Decorin prevents metastatic spreading of breast cancer. Oncogene 24: 1104-1110, 2005. (Pubitemid 40313888)
41. Reimer KA, Vander Heide RS, Richard VJ. Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 72: 13G-21G, 1993.
42. Rissanen TT, Ylä-Herttuala S. Current status of cardiovascular gene therapy. Mol Ther 15: 1233-1247, 2007. (Pubitemid 46965318)
43. Ruoslahti E. Structure and biology of proteoglycans. Annu Rev Cell Biol 4: 229-255, 1988.
44. Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, Colucci WS. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res 89: 351-356, 2001. (Pubitemid 34132674)
45. Santra M, Santra S, Zhang J, Chopp M. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3. J Neurochem 105: 324-337, 2008.
46. Schönherr E, Sunderkötter C, Schaefer L, Thanos S, Grässel S, Oldberg A, Iozzo RV, Young MF, Kresse H. Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 41: 499-508, 2004. (Pubitemid 39656675)
47. Shan K, Kurrelmeyer K, Seta Y, Wang F, Dibbs Z, Deswal A, Lee-Jackson D, Mann DL. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 12: 218-223, 1997. (Pubitemid 27252528)
48. Shi Y, Massagué J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700, 2003. (Pubitemid 36724933)
49. Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293: H1308-H1314, 2007.
50. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 46: 250-256, 2000.
51. Takemura G, Ohno M, Hayakawa Y, Misao J, Kanoh M, Ohno A, Uno Y, Minatoguchi S, Fujiwara T, Fujiwara H. Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res 82: 1130-1138, 1998. (Pubitemid 28311121)
52. Tran KT, Lamb P, Deng JS. Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Dermatol Sci 40: 11-20, 2005. (Pubitemid 41383893)
53. Weisman HF, Bush DE, Mannisi JA, Weisfeldt ML, Healy B. Cellular mechanisms of myocardial infarct expansion. Circulation 78: 186-201, 1988. (Pubitemid 18180460)
54. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346: 281-284, 1990. (Pubitemid 20227409)
55. Yin FC. Ventricular wall stress. Circ Res 49: 829-842, 1981.
56. Zaman AK, French CJ, Schneider DJ, Sobel BE. A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart. Exp Biol Med (Maywood) 234: 246-254, 2009.